- About the DEUEL Conference
- DEUEL Board
- The Havel Lecture
- Program
- Registration/Housing
- PostDocs & Trainees
- Speaker Information
- Hotel
- Sponsors
- 2010 List of Registrants
Program
|
2011 DEUEL Program Chair Jay Horton |
|
2011 DEUEL Program Co-Chair Jay Heinecke |
2011 Deuel Conference on Lipids, March 1–4, 2011
Silverado Resort, Napa, California
Preliminary Meeting Program
Wednesday, March 2, 8:45 AM to 12:00 PM
Session 1 Obesity, Metabolic Syndrome and Insulin Resistance
“The Skinny on Fat: Lipolysis and Fatty Acid Utilization in Adipocytes”
Hei Sook Sul, University of California, Berkeley
“Role of GPIHBP1 in Triglyceride Metabolism and Chylomicronemia Syndrome”
Anne Beigneux, University of California, Los Angeles
“Protein Kinase IKK-epsilon Regulates Energy Balance in Obese Mice”
Alan Saltiel, University of Michigan
“To be announced”
Joseph L. Goldstein, University of Texas Southwestern, Dallas, TX
“To be announced”
Michael S. Brown, University of Texas Southwestern, Dallas, TX
Wednesday, March 2, 7:30 to 9:30 PM
The Havel Lecture
“LXR Signaling in Macrophage Biology and Atherosclerosis”
Chris Glass, University of California, San Diego
Wine reception and Trainees’ Poster Session
Thursday, March 3, 8:45 AM to 12:00 PM
Session 2 Systems Biology
The Journal of Lipid Research Lecture
“Cardiovascular Networks: Systems-based Approaches to Cardiovascular Disease”
Jake Lusis, University of California, Los Angeles
“Evolutionary Conservation and Adaptation in the Mechanisms that Regulate SREBP Action”
Tim Osborne, Sanford-Burnham Medical Research Institute, Orlando, FL
“PNPLA3 to Pâté”
Helen Hobbs, University of Texas Southwestern, Dallas, TX
“Toward metabolomic signatures of cardiovascular disease”
Robert Gerszten, Harvard University, Charlestown, MA
Thursday, March 3, 7:30-9:30 PM
Session 3 Macrophages and Inflammation
“Role of HDL, ABCA1 and ABCG1 Transporters in Cholesterol Efflux and Immune Responses”
Alan Tall, Columbia University
“Inflammation, Macrophages, and Insulin Resistance”
Jerrold Olefsky, University of California, San Diego
“Regulation of the Migration and Survival of Monocyte Subsets by Chemokine Receptors and its Relevance to Atherosclerosis”
Gwen Randolph, Mount Sinai School of Medicine
Friday, March 4, 8:30 AM to 12:00 PM
Session 4 Therapeutics/Diagnostics/Pharmacology
“Novel Approaches to Modulation of PCSK9 and LDL Lowering in Humans”
Mark Sleeman, Regeneron
“Update on Phase III Data for the CETP Inhibitor Anacetrapib”
Yale Mitchel, Merck Research Labs